Animal cloning and the FDA--the risk assessment paradigm under public scrutiny

Larisa Rudenko; John C Matheson; Stephen F Sundlof

doi:10.1038/nbt0107-39

Animal cloning and the FDA--the risk assessment paradigm under public scrutiny

Nat Biotechnol. 2007 Jan;25(1):39-43. doi: 10.1038/nbt0107-39.

Authors

Larisa Rudenko¹, John C Matheson, Stephen F Sundlof

Affiliation

¹ Center for Veterinary Medicine, US Food and Drug Administration, Department of Health and Human Services, 7500 Standish Place, Rockville, Maryland 20855, USA. larisa.rudenko@fda.hhs.gov

PMID: 17211392
DOI: 10.1038/nbt0107-39

Abstract

The evidence gathered thus far--ultimately to be published in the Draft Risk Assessment on Animal Cloning--indicates that there are no unique risks associated with animal cloning.

Publication types

Review

MeSH terms

Animals
Cloning, Organism*
Consumer Product Safety*
Food, Genetically Modified*
Government Regulation*
Organisms, Genetically Modified*
Public Opinion
Risk Assessment / methods*
Risk Factors
United States
United States Food and Drug Administration*